Insys Therapeutics Competitors and Similar CompaniesClear all

Assertio's competitors and similar companies include AstraZeneca and BeyondSpring.

	Assertio Assertio (formerly Depomed) is a specialty pharmaceutical company focused on developing and commercializing products to treat pain and other central nervous system conditions.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.	BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
Founding Date	Founding Date 1995	Founding Date 1999	Founding Date 2010
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development life sciences pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations Lake Forest, US HQ	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more	Locations Florham Park, US HQ
Employees	Employees 3058% increase	Employees 94,300	Employees 4014% increase
Valuation ($)	Valuation ($) 104.9 m	Valuation ($) 2.7 b	Valuation ($) 89.4 m
Financial
Revenue (est.)	Revenue (est.) $118.7m (FY, 2025)	Revenue (est.) $58.7b (FY, 2025)	Revenue (est.) N/A
Net income	Net income ($30.4m) (FY, 2025)	Net income $10.2b (FY, 2025)	Net income ($16.7m) (FY, 2024)
Operating ⚠
Patents (US)	Patents (US) 12 (FY, 2020)	Patents (US) N/A	Patents (US) 20 (Mar, 2020)
Funding
Total funding raised	Total funding raised $ 42.5m	Total funding raised $ 1b	Total funding raised $ 36.1m